Digital Pathology Market, by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Digital pathology is the process of digitizing glass slides using a whole slide image scanner and then analyzing the digital images using an image viewer, typically on a computer monitor or mobile device. Digital pathology offers a better viewing experience, which enhances analysis. This lowers diagnostic error rates. These tools additionally provide service providers immediate access to earlier cases for comparison. These advanced systems store data for use in long-term predictive analysis. Specimens are barcoded to reduce the chance of misidentification. Also, this removes concerns about lost data due to slide breakage. In the modern world, digital pathology has many benefits including improved disease diagnosis accuracy, quicker recovery times, increased pathologist productivity, and so on. As a result of these benefits, healthcare facilities are increasingly using digital pathology platforms for disease diagnosis, and major market players are getting involved in product launch process.
Market Dynamics
The use of new technologies for the development of innovative digital pathology platform is expected to drive the growth of the global digital pathology market over the forecast period. For instance, in June 2022, Tribun Health, a software company, launched TeleSlide Patho 5, an online telepathology platform which is utilized for sharing digital pathology slides and other multimedia documents.
Increasing number of partnerships by the market players is expected to drive the market growth over forecast period. For instance, on September 23, 2022, Paige AI, Inc., a provider of digital pathology solutions and clinical AI applications, and OptraScan, a producer of whole slide scanners, announced a partnership to streamline the adoption of digital pathology technology in the U.S., European Union countries, and U.K. The companies’ goal is to lower obstacles to glass pathology slide digitization, which will improve oncology and pathology workflows.
Key features of the study:
This report will provide in-depth analysis of the Global Digital Pathology Market , and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It will elucidate potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Digital Pathology Market based on the following parameters–company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Leica Biosystems Nussloch GmbH, Olympus Corporation, F. Hoffmann-La Roche Ltd., Merck KGaA, GE Healthcare, Mikroscan Technologies, Inc., Koninklijke Philips N.V., Sectra AB, Propath UK Limited, Inspirata, Inc., Hamamatsu Photonics, Inc., OracleBio Limited, MD Biosciences, Aiforia, Xybion Digital Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Global Digital Pathology Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Digital Pathology Market
Detailed Segmentation:
Global Digital Pathology Market , By Product Type:
Image Analysis Software
Scanner
Bright Field Scanner
Fluorescence Scanner
Services
Installation and Integration
Maintenance Services
Consulting Services
Global Digital Pathology Market, By Therapeutic Area:
Oncology
Hematology
Autoimmune Disorders
Dermatology
Others
Global Digital Pathology Market, By Technology:
Immunohistochemistry
ISH & FISH
Immunofluorescence
Others
Global Digital Pathology Market, By End User:
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Hospital Laboratories
Others
Global Digital Pathology Market , By Region:
North America
By Country:
U.S.
Canada
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Country:
GCC
Israel
Rest of Middle East
Middle East
By Country/Region:
South Africa
Central Africa
North Africa
Africa
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Leica Biosystems Nussloch GmbH *
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Olympus Corporation
F. Hoffmann-La Roche Ltd.
Merck KGaA
GE Healthcare
Mikroscan Technologies, Inc.
Koninklijke Philips N.V.
Sectra AB
Propath UK Limited
Inspirata, Inc.
Hamamatsu Photonics, Inc.
OracleBio Limited
MD Biosciences
Aiforia
Xybion Digital Inc.
“*” marked represents similar segmentation in other categories in the respective section.